Ultimately, most agree that investing in research and patient navigation – including second opinions – will result in savings that outstrip spending.

If you want to reduce the cost of insulin, then do it. If you just want to spread the cost of insulin across more people, admit it.

Payers must be prepared to pay objectively fair rates for services when the claims are first received, as well as present a defensible offer.

Does the No Surprises Act sabotage efforts to achieve equitable network arrangements?

To understand the actual impact of the act, we must dissect three important topics: First, the actual scope.